CAD 0.01
(0.0%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 1.17 Million CAD | 42.75% |
2022 | 821 Thousand CAD | 517.29% |
2021 | 133 Thousand CAD | 1230.0% |
2020 | 10 Thousand CAD | 118.15% |
2019 | 4584.00 CAD | -72.9% |
2018 | 16.91 Thousand CAD | 0.0% |
2017 | - CAD | 0.0% |
2016 | - CAD | 0.0% |
2015 | - CAD | 0.0% |
2014 | - CAD | 0.0% |
2013 | - CAD | 0.0% |
2012 | - CAD | 0.0% |
2011 | - CAD | 0.0% |
2010 | - CAD | 0.0% |
2009 | - CAD | 0.0% |
2008 | - CAD | 0.0% |
2007 | - CAD | 0.0% |
2006 | - CAD | 0.0% |
2005 | - CAD | 0.0% |
2004 | - CAD | 0.0% |
2003 | - CAD | 0.0% |
2002 | - CAD | 0.0% |
2001 | - CAD | 0.0% |
2000 | - CAD | 0.0% |
1999 | - CAD | 0.0% |
1998 | - CAD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q1 | 51 Thousand CAD | -42.7% |
2024 Q2 | 1.02 Million CAD | 1911.76% |
2023 Q2 | 135 Thousand CAD | -50.73% |
2023 Q1 | 274 Thousand CAD | -46.27% |
2023 Q4 | 89 Thousand CAD | -86.8% |
2023 Q3 | 674 Thousand CAD | 399.26% |
2023 FY | 1.17 Million CAD | 42.75% |
2022 FY | 821 Thousand CAD | 517.29% |
2022 Q2 | 262 Thousand CAD | 0.0% |
2022 Q3 | 49 Thousand CAD | -81.3% |
2022 Q4 | 510 Thousand CAD | 940.82% |
2022 Q1 | - CAD | -100.0% |
2021 Q3 | 2000.00 CAD | -98.28% |
2021 FY | 133 Thousand CAD | 1230.0% |
2021 Q1 | 6000.00 CAD | -21.47% |
2021 Q2 | 116 Thousand CAD | 1833.33% |
2021 Q4 | 9000.00 CAD | 350.0% |
2020 FY | 10 Thousand CAD | 118.15% |
2020 Q1 | 2160.00 CAD | 419.23% |
2020 Q4 | 7640.00 CAD | 3720.0% |
2020 Q2 | - CAD | -100.0% |
2020 Q3 | 200.00 CAD | 0.0% |
2019 FY | 4584.00 CAD | -72.9% |
2019 Q3 | - CAD | -100.0% |
2019 Q2 | 1523.00 CAD | -50.25% |
2019 Q1 | 3061.00 CAD | -60.83% |
2019 Q4 | 416.00 CAD | 0.0% |
2018 FY | 16.91 Thousand CAD | 0.0% |
2018 Q4 | 7814.00 CAD | -14.12% |
2018 Q3 | 9099.00 CAD | 0.0% |
2018 Q2 | - CAD | 0.0% |
2018 Q1 | - CAD | 0.0% |
2017 Q3 | - CAD | 0.0% |
2017 Q4 | - CAD | 0.0% |
2017 FY | - CAD | 0.0% |
2017 Q1 | - CAD | 0.0% |
2017 Q2 | - CAD | 0.0% |
2016 Q2 | - CAD | 0.0% |
2016 Q3 | - CAD | 0.0% |
2016 Q4 | - CAD | 0.0% |
2016 FY | - CAD | 0.0% |
2016 Q1 | - CAD | 0.0% |
2015 Q4 | - CAD | 0.0% |
2015 Q3 | - CAD | 0.0% |
2015 Q2 | - CAD | 0.0% |
2015 Q1 | - CAD | 0.0% |
2015 FY | - CAD | 0.0% |
2014 Q2 | - CAD | 0.0% |
2014 FY | - CAD | 0.0% |
2014 Q1 | - CAD | 0.0% |
2014 Q4 | - CAD | 0.0% |
2014 Q3 | - CAD | 0.0% |
2013 Q4 | - CAD | 0.0% |
2013 Q2 | - CAD | 0.0% |
2013 Q3 | - CAD | 0.0% |
2013 Q1 | - CAD | 0.0% |
2013 FY | - CAD | 0.0% |
2012 Q4 | - CAD | 0.0% |
2012 FY | - CAD | 0.0% |
2012 Q3 | - CAD | 0.0% |
2012 Q2 | - CAD | 0.0% |
2012 Q1 | - CAD | 0.0% |
2011 Q3 | - CAD | 0.0% |
2011 FY | - CAD | 0.0% |
2011 Q4 | - CAD | 0.0% |
2011 Q1 | - CAD | 0.0% |
2011 Q2 | - CAD | 0.0% |
2010 Q3 | - CAD | 0.0% |
2010 FY | - CAD | 0.0% |
2010 Q1 | - CAD | 0.0% |
2010 Q2 | - CAD | 0.0% |
2010 Q4 | - CAD | 0.0% |
2009 Q2 | - CAD | 0.0% |
2009 Q4 | - CAD | 0.0% |
2009 Q1 | - CAD | 0.0% |
2009 FY | - CAD | 0.0% |
2009 Q3 | - CAD | 0.0% |
2008 FY | - CAD | 0.0% |
2008 Q1 | - CAD | 0.0% |
2008 Q4 | - CAD | 0.0% |
2008 Q3 | - CAD | 0.0% |
2008 Q2 | - CAD | 0.0% |
2007 Q1 | - CAD | 0.0% |
2007 FY | - CAD | 0.0% |
2007 Q4 | - CAD | 0.0% |
2007 Q3 | - CAD | 0.0% |
2007 Q2 | - CAD | 0.0% |
2006 Q4 | - CAD | 0.0% |
2006 FY | - CAD | 0.0% |
2006 Q1 | - CAD | 0.0% |
2006 Q2 | - CAD | 0.0% |
2006 Q3 | - CAD | 0.0% |
2005 FY | - CAD | 0.0% |
2005 Q1 | - CAD | 0.0% |
2005 Q2 | - CAD | 0.0% |
2005 Q3 | - CAD | 0.0% |
2005 Q4 | - CAD | 0.0% |
2004 Q3 | - CAD | 0.0% |
2004 Q4 | - CAD | 0.0% |
2004 Q2 | - CAD | 0.0% |
2004 Q1 | - CAD | 0.0% |
2004 FY | - CAD | 0.0% |
2003 FY | - CAD | 0.0% |
2003 Q4 | - CAD | 0.0% |
2003 Q3 | - CAD | 0.0% |
2003 Q2 | - CAD | 0.0% |
2003 Q1 | - CAD | 0.0% |
2002 Q1 | - CAD | 0.0% |
2002 FY | - CAD | 0.0% |
2002 Q2 | - CAD | 0.0% |
2002 Q4 | - CAD | 0.0% |
2002 Q3 | - CAD | 0.0% |
2001 Q2 | - CAD | 0.0% |
2001 Q3 | - CAD | 0.0% |
2001 FY | - CAD | 0.0% |
2001 Q4 | - CAD | 0.0% |
2001 Q1 | - CAD | 0.0% |
2000 Q4 | - CAD | 0.0% |
2000 FY | - CAD | 0.0% |
2000 Q3 | - CAD | 0.0% |
1999 FY | - CAD | 0.0% |
1998 FY | - CAD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Aurora Cannabis Inc. | 270.28 Million CAD | 99.566% |
Avicanna Inc. | 16.79 Million CAD | 93.02% |
Avant Brands Inc. | 26.34 Million CAD | 95.551% |
Cardiol Therapeutics Inc. | - CAD | -Infinity% |
Crescita Therapeutics Inc. | 17.52 Million CAD | 93.311% |
Knight Therapeutics Inc. | 328.19 Million CAD | 99.643% |
MediPharm Labs Corp. | 33.06 Million CAD | 96.455% |
OrganiGram Holdings Inc. | 149.2 Million CAD | 99.215% |
Canopy Growth Corporation | 297.14 Million CAD | 99.606% |
Auxly Cannabis Group Inc. | 101.07 Million CAD | 98.84% |